CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Appraisal of re-irradiation for the recurrent glioblastoma in the era of MGMT promotor methylation

Il Han Kim

Radiation Oncology Journal. 2019;37(1):1-12. Published online 2019 March 31 DOI: https://doi.org/10.3857/roj.2019.00171

Appraisal of re-irradiation for the recurrent glioblastoma in the era of MGMT promotor methylation

Il Han Kim

Radiation Oncology Journal. 2019;37(1):1-12

Link1

Link2 Link3

8703 Clinical effect of hypo-fractionated high-dose irradiation on local control of glioblastoma owing to the status of MGMT promotor methylation

T. Iuchi, K. Hatano, H. Kageyama, T. Sakaida, K. Kawasaki, A. Nakagawara

European Journal of Cancer Supplements. 2009;7(2):494

Link1 Link2

ACTR-05. PROCARBAZINE AND CCNU CHEMOTHERAPY FOR RECURRENT GLIOBLASTOMA WITH MGMT PROMOTER METHYLATION

Yong Kil Hong, Seung Ho Yang

Neuro-Oncology. 2019;21(Supplement_6):vi13-vi13

Link1

Link2

Long-term daily temozolomide with dose-dependent efficacy in MGMT promotor methylation negative recurrent high-grade astrocytoma

Zhengqiu Zhou, Tracy A. Howard, John L. Villano

Cancer Chemotherapy and Pharmacology. 2017;80(5):1043-1046

Link1 Link2

Link3

LARGE VOLUME RE-IRRADIATION IS A VIABLE OPTION IN PATIENTS WITH RECURRENT REFRACTORY GLIOBLASTOMA

Michael Back, Joseph Chan, Dasantha Jayamanne

Neuro-Oncology. 2018;20(suppl_5):v353-v353

Link1

PATH-04. INFLUENCE OF INDIVIDUAL CpG METHYLATION STATUS OF THE MGMT PROMOTOR ON OUTCOME IN ADULT PATIENTS WITH GLIOBLASTOMA MULTIFORME RECEIVING ALKYLATING AGENT TREATMENT

Sebastian Siller, Michael Lauseker, Armin Giese, Joerg-Christian Tonn, Karim-Maximilian Niyazi, Niklas Thon, Bogdana Suchorska, Friedrich-Wilhelm Kreth

Neuro-Oncology. 2019;21(Supplement_6):vi143-vi143

Link1

Link2

NIMG-73. RADIOMICS OF GLIOBLASTOMA FOR PREDICTING MGMT PROMOTOR METHYLATION STATUS AND PROGNOSIS

Takahiro Sasaki, Manabu Kinoshita, Koji Fujita, Hideyuki Arita, Takehiro Uda, Hisahiro Tsuyuguchi, Nobihude Hayashi, Junya Fukai, Yuji Uematsu, Kanji Mori, Yoshiko Okita, Masahiro Nonaka, Syusuke Moriuchi, Rintaro Hashizume, Naoyuki Nakao, Yonehiro Kanemura

Neuro-Oncology. 2018;20(suppl_6):vi192-vi192

Link1

3D Conformal Re-Irradiation with Temozolamide for Recurrent Glioblastoma: A Prospective Cohort Study

Ghada Ezzat Eladawei, Rasha Mohamed Abdellatif

Journal of Cancer Therapy. 2019;10(08):619-631

Link1 Link2

The Potential Effect of the IDH1 Mutation and MGMT Gene Promotor Methylation on the Control of Glioblastoma-Associated Epilepsy in Patients Receiving Anti-Epileptic Agents and Chemotherapies

Maher Kurdi, Nadeem Shafique Butt, Saleh Baeesa, Badrah Alghamdi, Yazid Maghrabi, Anas Bardeesi, Rothaina Saeedi, Fahad Alghamdi, Najla Alghanmi, Mohammed O. Bari, Alaa Samkari, Ahmed I. Lary, Taghreed Alsinani

. 2021;

Link1 Link2

EP-1071: Outcome after re-irradiation for recurrent glioblastoma

K. Zwirner, F. Paulsen, G. Henke, C. Braun, M. Skardelly, D. Zips, F. Eckert

Radiotherapy and Oncology. 2014;111:S10

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Radiat Oncol J has participated in CrossRef Text and Data Mining service since October 29, 2014.